Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Sino Biopharmaceutical Ltd (1177)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.72 +0.22    +4.89%
24/06 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG8167W1380 
  • Volume: 86,240,603
  • Bid/Ask: 4.71 / 4.72
  • Day's Range: 4.47 - 4.75
Sino Biopharmaceutical 4.72 +0.22 +4.89%
IndustryPharmaceuticals
SectorHealthcare
Employees

25579

Equity Type

ORD

Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is principally engaged in the related medical and hospital business.

Top Executives

Name Age Since Title
Mingqin Li 62 2015 VP & Executive Director
Hsin Tse 51 - VP & Executive Director
Yi Li 59 2020 CEO & Executive Director
Zhoushan Tian 57 2015 Executive Director
Cheung Ling Cheng 57 2017 Executive Vice Chairwoman of the Board
Ping Tse 69 2016 Founder & Senior Vice Chairman
Hong Lu 52 2015 Independent Non-Executive Director
Kwok Tung Li 67 2020 Independent Non-Executive Director
Y. Y. Tse 29 2015 Executive Chairman of the Board
Shanchun Wang 54 2015 Executive Director
Lu Fu Zhang 65 2015 Independent Non-Executive Director
Dakui Li 78 2004 Independent Non-Executive Director
Zhengfei Lu 59 2005 Independent Non-Executive Director
Eric S. Y. Tse 26 2019 Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

1177 Comments

Write your thoughts about Sino Biopharmaceutical Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jame Megueni
CONCORIDEA Feb 15, 2022 9:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
HSBC Global Research Cuts SINO BIOPHARM TP to $9, Rated Buy
Jame Megueni
CONCORIDEA Jan 20, 2022 8:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
UBS Adds SINO BIOPHARM TP to $11.6, Rated Buy
Jame Megueni
CONCORIDEA Sep 02, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
M Stanley Trims CHINA CINDA TP to $1.63; Rated Equalweight
Jame Megueni
CONCORIDEA Sep 02, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa Axes SINO BIOPHARM TP to $11; Rated Buy
Jame Megueni
CONCORIDEA Aug 18, 2021 11:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SINO BIOPHARM Shr Once Rebounds Over 9% as Interim NP May Hike Over 5x
Jame Megueni
CONCORIDEA Jul 27, 2021 10:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SINO BIOPHARM Repurchases $28.53M Shrs; Tse Ping, Tse Hsin Splurge Over $100M to Add Stakes
Jarvis Wang
Jarvis Wang Jun 01, 2021 9:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WHO agree SinoVac into EUA list at Jun 01, that Sino Biopharm have 15.3%
Jame Megueni
CONCORIDEA May 24, 2021 10:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Macquarie Upgrades SINO BIOPHARM to *Outperform* with $10.46 TP
Jame Megueni
CONCORIDEA Mar 15, 2021 10:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JPM Raises SINO BIOPHARM TP to $13.5; Rated ***Overweight***
Jame Megueni
CONCORIDEA Mar 14, 2021 10:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa Ramps up SINO BIOPHARM  TP to $12; Rated ***Buy***
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email